肺动脉高压中依前列醇相关的腹水
Epoprostenol-associated ascites in pulmonary arterial hypertension.
作者信息
Schoenberg Noah C, Ruopp Nicole F, Parikh Raj D, Farber Harrison W
机构信息
Beth Israel Deaconess Medical Center Boston Massachusetts USA.
Tufts Medical Center Boston Massachusetts USA.
出版信息
Pulm Circ. 2022 Jun 7;12(2):e12092. doi: 10.1002/pul2.12092. eCollection 2022 Apr.
Abstract
The development of ascites in pulmonary arterial hypertension (PAH) in the absence of pre-existing hepatic dysfunction is usually associated with decompensated right heart failure or cardiac cirrhosis. Ascites in PAH has rarely been associated with intravenous epoprostenol, a synthetic form of the prostaglandin PGI.
摘要
在没有预先存在的肝功能障碍的情况下，肺动脉高压（PAH）患者出现腹水通常与失代偿性右心衰竭或心源性肝硬化有关。PAH患者的腹水很少与静脉注射依前列醇（一种前列腺素PGI的合成形式）有关。
相似文献
1
Epoprostenol-associated ascites in pulmonary arterial hypertension.肺动脉高压中依前列醇相关的腹水
Pulm Circ. 2022 Jun 7;12(2):e12092. doi: 10.1002/pul2.12092. eCollection 2022 Apr.
2
Transition from Intravenous Epoprostenol to Treprostinil Due to Intolerable Side Effects in Patients With Pulmonary Arterial Hypertension.肺动脉高压患者因无法耐受的副作用从静脉注射依前列醇转换为曲前列尼尔治疗
Am J Cardiol. 2023 Nov 1;206:31-34. doi: 10.1016/j.amjcard.2023.08.078. Epub 2023 Sep 8.
3
Epoprostenol Therapy for Pulmonary Arterial Hypertension.依前列醇治疗肺动脉高压
Acta Med Okayama. 2015;69(3):129-36. doi: 10.18926/AMO/53519.
4
Thyroid Dysfunction in Patients with Pulmonary Artery Hypertension (PAH): The Effect of Therapies Affecting the Prostanoid Pathway.肺动脉高压（PAH）患者的甲状腺功能障碍：影响前列环素途径的治疗的影响。
Lung. 2019 Dec;197(6):761-768. doi: 10.1007/s00408-019-00283-8. Epub 2019 Nov 6.
5
Epoprostenol sodium for treatment of pulmonary arterial hypertension.依前列醇钠治疗肺动脉高压
Vasc Health Risk Manag. 2015 May 14;11:265-70. doi: 10.2147/VHRM.S50368. eCollection 2015.
6
A Case of Giant Goiter Associated with Airway Stenosis Caused by Long-Term Intravenous Epoprostenol Therapy for Idiopathic Pulmonary Arterial Hypertension.一例因特发性肺动脉高压长期静脉输注依前列醇治疗导致巨大甲状腺肿合并气道狭窄的病例。
J Clin Med. 2023 Oct 4;12(19):6359. doi: 10.3390/jcm12196359.
7
Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry.重度特发性、遗传性或食欲抑制剂相关性肺动脉高压患者目前使用依前列醇的情况：来自法国肺动脉高压注册研究的数据
Int J Cardiol. 2014 Apr 1;172(3):561-7. doi: 10.1016/j.ijcard.2013.12.313. Epub 2014 Jan 22.
8
Acute hemodynamic effects of intravenous adenosine in patients with associated pulmonary arterial hypertension: Comparison with intravenous epoprostenol.伴有肺动脉高压的患者静脉内给予腺苷的急性血液动力学效应：与静脉内依前列醇的比较。
Pulm Pharmacol Ther. 2018 Apr;49:147-151. doi: 10.1016/j.pupt.2017.06.005. Epub 2017 Jun 19.
9
Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus erythematosus.成功将静脉内依前列醇转换为口服塞来昔帕格和吸入伊洛前列素治疗系统性红斑狼疮相关严重肺动脉高压的病例。
Mod Rheumatol Case Rep. 2022 Jun 24;6(2):183-188. doi: 10.1093/mrcr/rxac009.
10
Use of Epoprostenol in the Treatment of Pulmonary Arterial Hypertension.依前列醇在肺动脉高压治疗中的应用。
Cureus. 2021 Sep 22;13(9):e18191. doi: 10.7759/cureus.18191. eCollection 2021 Sep.
本文引用的文献
1
Massive ascites in pulmonary arterial hypertension: caution with epoprostenol.
Ann Am Thorac Soc. 2013 Dec;10(6):726-7. doi: 10.1513/AnnalsATS.201305-115LE.
2
How has epoprostenol changed the outcome for patients with pulmonary arterial hypertension?依前列醇如何改变肺动脉高压患者的治疗结果？
Int J Clin Pract Suppl. 2010 Nov(168):23-32. doi: 10.1111/j.1742-1241.2010.02525.x.
3
Marked hemodynamic improvements by high-dose epoprostenol therapy in patients with idiopathic pulmonary arterial hypertension.大剂量依前列醇治疗特发性肺动脉高压患者的血流动力学显著改善。
Circ J. 2010 Oct;74(10):2200-5. doi: 10.1253/circj.cj-10-0190. Epub 2010 Aug 6.
4
The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension.慢性前列环素治疗对原发性肺动脉高压患者心输出量及症状的影响。
J Am Coll Cardiol. 1999 Oct;34(4):1184-7. doi: 10.1016/s0735-1097(99)00320-4.
5
A survey of diagnostic practices and the use of epoprostenol in patients with primary pulmonary hypertension.一项关于原发性肺动脉高压患者诊断方法及依前列醇使用情况的调查。
Chest. 1998 Nov;114(5):1269-75. doi: 10.1378/chest.114.5.1269.
6
Pharmacodynamic profile of prostacyclin.
Am J Cardiol. 1995 Jan 19;75(3):3A-10A. doi: 10.1016/s0002-9149(99)80377-4.
7
Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin).原发性肺动脉高压的治疗：静脉注射依前列醇（前列环素）。
Br Heart J. 1987 Mar;57(3):270-8. doi: 10.1136/hrt.57.3.270.
8
Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.
Ann Intern Med. 1990 Apr 1;112(7):485-91. doi: 10.7326/0003-4819-112-7-485.
Zotero 插件